Glaukos (GKOS) Non-Current Debt (2014 - 2015)
Glaukos (GKOS) reported Non-Current Debt of $765000.0 for Q4 2015, down 91.47% year-over-year from $9.0 million in Q4 2014, and down 74.83% on a QoQ basis from $3.0 million in Q3 2015.
Glaukos (GKOS) has 2 years of Non-Current Debt data on file, last reported at $765000.0 in Q4 2015.
- Quarterly Non-Current Debt fell 91.47% year-over-year to $765000.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $765000.0 (down 91.47% YoY) and the FY2015 annual result came in at $765000.0, down 91.47% from the prior year.
- Non-Current Debt slipped to $765000.0 in Q4 2015 per GKOS's latest filing, from $3.0 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $11.6 million in Q2 2015 and bottomed at $765000.0 in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 27.88 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.81 Bn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 765,000.00 |
| Dec 31, 2015 | 765,000.00 |
| Sep 30, 2015 | 3.04 Mn |
| Sep 30, 2015 | 3.04 Mn |
| Jun 30, 2015 | 11.64 Mn |
| Jun 30, 2015 | 11.64 Mn |
| Dec 31, 2014 | 8.97 Mn |
| Dec 31, 2014 | 8.97 Mn |